Hasan Huseyin Kilic

Hasan Huseyin Kilic

Auto-generated profile, based on publicly available information

Hasan Huseyin Kilic

Istanbul Dogus Universty, Hisar Hospital Intercontinental

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2023 in Pakistan Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
RGRamazan Gozukucuk
Ramazan Gozukucuk
HKHasan Huseyin Kilic
Hasan Huseyin Kilic
Objective: To examine the use of anti-cytokine treatment in critical COVID-19 patients and their association with the frequency of CMV cases, viral load level, and mortality in these patients. Methods: This is a retrospective study. A total of 170 critical and/or intensive care patients with COVID-19 admitted to Hisar Hospital Intercontinental from March 15, 2020, to December 31, 2021 were divided into the use of anti-cytokine treatment group and the no anti-cytokine treatment group. Furthermore, the relationship between CMV reactivation, mortality and anti-cytokine treatment in patients was also examined. Results: A total of 170 critical COVID-19 patients were included in the study, three of them were excluded. One hundred sixty seven were included in the study of which 38 (22.7%) were found to be CMV DNA positive. As an anti-cytokine treatment, it was observed that tocilizumab was used in 53 patients, anakinra was used in 27 patients, and no anti-cytokine treatment was used in 77 patients. CMV positivity in patients treated with anti-cytokines (31.11%) was found to be significantly higher than in patients who were not treated with it (16.88%) (p:0.033). Furthermore, it was determined that anti-cytokine treatment significantly decreased mortality (p: 0.003) and that there was no significant relationship between CMV reactivation and mortality (p: 0.399). Conclusion: Even though CMV reactivation was high in critical COVID-19 patients who received anti-cytokine treatment, decrease in mortality were observed with early diagnosis and effective treatment. Therefore, CMV infection should be considered in patients receiving immunosuppressive treatment. Clinical Trial Registration: HisarIH-101/NCT05419206 doi: https://doi.org/10.12669/pjms.39.5.7301 How to cite this: Gozukucuk R, Kilic HH. The relationship between CMV reactivation, anti-cytokine treatment and mortality in critical COVID-19 patients. Pak J Med Sci. 2023;39(5):1286-1290. doi: https://doi.org/10.12669/pjms.39.5.7301 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

17 March 2021 in Urologia Journal
Verified
Journal Article
Closed access
PDF file
BCBasri Cakiroglu
Basri Cakiroglu
CKCevdet Kaya
Cevdet Kaya
HKHasan Huseyin Kilic
Hasan Huseyin Kilic
SASuleyman Hilmi Aksoy
Suleyman Hilmi Aksoy
RGRamazan Gözüküçük
Ramazan Gözüküçük
Objective: This research aimed at evaluating the changing conditions and experiences of urological practice during the COVID-19 pandemic. Methods: The data of all patients who were admitted to outpatient clinics at Hisar Intercontinental Hospital or the hospital’s online patient portal system between March 11th and May 30th, 2020 were analyzed retrospectively. Of all patients, 545 in outpatient clinics and 25 in online portal system, (17%) were hospitalized for medical treatment, and 53 underwent surgery. There were 1032 patients admitted to Urology Clinics and 104 patients who underwent surgery in the same period of 2019. The pre-operative assessment of patients who were candidates of urological surgery included certain criteria for COVID-19. Results: Of patients included in this study, the median age was 41 years (18–90). The mean hospital stay was 1 day (1–12), and the mean duration of operation was 25 min (3–250). Thirty-seven patients (69.8%) underwent general anesthesia, while only 11(20.8%) underwent combined spinal epidural anesthesia. Four patients (7.5%) required local and only one patient (1.9%) underwent sedo-analgesia. Complications were encountered in six patients (11.4%), urosepsis in two, pneumonia in one, and urinary tract infection in three patients. Compared to last year’s numbers, the number of patients admitted to the hospital’s outpatient clinic and that of hospitalized patients decreased by 47.2% and 49.1%, respectively. Conclusion: Emergent surgeries in urological practices can be performed safely under routine preoperative testing for COVID-19 and with the use of adequate protective equipment for both the surgical team and the patient.